Related Experiment Video
Updated: Feb 14, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Use of Glucocorticoids for the Fetus and Preterm Infant
1University of New Mexico School of Medicine, 2211 Lomas Boulevard, Albuquerque, NM 87131, USA.
Insights
Glucocorticoid therapy improves outcomes for preterm infants by aiding lung development and adrenal function. While generally beneficial, dexamethasone may pose greater risks to brain development compared to other glucocorticoids.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Pharmacology
Background:
- Glucocorticoids have been used for over 40 years to prepare fetuses and preterm infants for life after birth.
- Treatment addresses cortisol replacement for immature hypothalamic-pituitary-adrenal axes and prevents chronic lung disease.
- Concerns exist regarding potential neurodevelopmental adverse effects, particularly with dexamethasone.
Purpose of the Study:
- To review the established benefits and potential risks of glucocorticoid therapy in preterm infants.
- To compare the safety profiles of different glucocorticoids, focusing on neurodevelopmental outcomes.
Main Methods:
- Literature review of studies on glucocorticoid use in neonatal care.
- Analysis of clinical data comparing dexamethasone with other glucocorticoids regarding efficacy and safety.
- Examination of long-term effects on infant development and organ function.
Main Results:
- Glucocorticoid treatment significantly improves overall outcomes for preterm infants.
- Dexamethasone therapy has been associated with more frequent negative effects on brain development and function.
- The benefits of glucocorticoids for lung function and adrenal sufficiency are well-documented.
Conclusions:
- Glucocorticoid therapy remains a critical intervention for improving the survival and health of preterm infants.
- Careful consideration of the specific glucocorticoid agent and potential neurodevelopmental risks is warranted.
- Ongoing research aims to optimize glucocorticoid use while minimizing adverse effects in vulnerable neonates.
Abstract:
The soon-to-be-delivered fetus and preterm infant have been treated with glucocorticoids to prepare for postnatal life, historically for more than 40 years. The use of glucocorticoids is as much for replacement of cortisol in the setting of a poorly functioning hypothalamic-pituitary-adrenal axis in the preterm infant, as it is for prevention of long-term lung dysfunction. Potential negative effects of glucocorticoid treatment on brain development and function have been observed more often with dexamethasone therapy than with use of other glucocorticoids. Overall, glucocorticoid treatment has improved the outcome of the preterm infant.
Related Concept Videos
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drug Dosing: Infants and Children
Hypothalamic-Pituitary Axis
Theory of Romantic Attachment in Adulthood

